Prevalence of hypermutator isolates of Achromobacter spp. from cystic fibrosis patients

被引:9
|
作者
Ridderberg, Winnie [1 ]
Handberg, Kurt Jensen [1 ]
Norskov-Lauritsen, Niels [1 ]
机构
[1] Aarhus Univ Hosp, Dept Clin Microbiol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark
关键词
Hypermutation; Cystic fibrosis; Achromobacterspp; Chronic infection; PSEUDOMONAS-AERUGINOSA; MISMATCH REPAIR; STENOTROPHOMONAS-MALTOPHILIA; MOLECULAR CHARACTERIZATION; GENETIC ADAPTATION; HIGH-FREQUENCY; XYLOSOXIDANS; INFECTIONS; STRAINS; RESISTANCE;
D O I
10.1016/j.ijmm.2020.151393
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bacteria colonising the lungs of cystic fibrosis (CF) patients encounter high selective pressures. Hypermutation facilitates adaptation to fluctuating environments, and hypermutator strains are frequently isolated from CF patients. We investigated the prevalence of hypermutator isolates of Achromobacter spp. among patients affiliated with the CF Centre in Aarhus, Denmark. By exposure to rifampicin, the mutation frequency was determined for 90 isolates of Achromobacter spp. cultured from 42 CF patients; 20 infections were categorised as chronic, 22 as intermittent. The genetic mechanisms of hypermutation were examined by comparing DNA repair gene sequences from hypermutator and normomutator isolates. Achromobacter spp. cultured from 11 patients were categorised as hypermutators, and this phenotype was exclusively associated with chronic infections. Isolates of the Danish epidemic strain (DES) of Achromobacter ruhlandii cultured from patients from both Danish CF centres showed elevated mutation frequencies. The hypermutator state of Achromobacter spp. was most commonly associated with nonsynonymous mutations in the DNA mismatch repair gene mutS; a single clone had developed a substitution in the S-adenosyl-L-methionine-dependent methyltransferase putatively involved in DNA repair mechanisms, but not previously linked to the hypermutator phenotype. Hypermutation is prevalent among clinical isolates of Achromobacter spp. and could be a key determinant for the extraordinary adaptation and persistence of DES.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Evidence of persistence of Prevotella spp. in the cystic fibrosis lung
    Gilpin, D. F.
    Nixon, K. A.
    Bull, M.
    McGrath, S. J.
    Sherrard, L.
    Rolain, J. M.
    Mahenthiralingam, E.
    Elborn, J. S.
    Tunney, M. M.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 66 (06) : 825 - 832
  • [22] Study of a Cohort of Patients With Cystic Fibrosis and Isolation of Scedosporium spp.
    Erro Iribarren, Marta
    Giron Moreno, Rosa Maria
    Diab Caceres, Layla
    Pastor Sanz, Maria Teresa
    Buendia Moreno, Buenaventura
    Alarcon Cavero, Teresa
    Granja Torrecillas, Silvia
    Zurita Cruz, Nelly Daniela
    Ancochea Bermudez, Julio
    ARCHIVOS DE BRONCONEUMOLOGIA, 2019, 55 (11): : 559 - 564
  • [23] Epidemiology and resistance of Achromobacter xylosoxidans from cystic fibrosis patients in Dijon, Burgundy: First French data
    Amoureux, Lucie
    Bador, Julien
    Siebor, Eliane
    Taillefumier, Nathalie
    Fanton, Annlyse
    Neuwirth, Catherine
    JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (02) : 170 - 176
  • [24] Multilocus Sequence Analysis of Isolates of Achromobacter from Patients with Cystic Fibrosis Reveals Infecting Species Other than Achromobacter xylosoxidans
    Ridderberg, Winnie
    Wang, Mikala
    Norskov-Lauritsen, Niels
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (08) : 2688 - 2694
  • [25] Prevalence and species distribution of Achromobacter sp cultured from cystic fibrosis patients attending the Aarhus centre in Denmark
    Gade, Sinne Soberg
    Norskov-Lauritsen, Niels
    Ridderberg, Winnie
    JOURNAL OF MEDICAL MICROBIOLOGY, 2017, 66 (05) : 686 - 689
  • [26] Clinical impact of Achromobacter xylosoxidans colonization/infection in patients with cystic fibrosis
    Firmida, M. C.
    Pereira, R. H. V.
    Silva, E. A. S. R.
    Marques, E. A.
    Lopes, A. J.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2016, 49 (04)
  • [27] In Vitro Activity of 22 Antibiotics against Achromobacter Isolates from People with Cystic Fibrosis. Are There New Therapeutic Options?
    Beauruelle, Clemence
    Lamoureux, Claudie
    Mashi, Arsid
    Ramel, Sophie
    Le Bihan, Jean
    Ropars, Thomas
    Dirou, Anne
    Banerjee, Anandadev
    Tande, Didier
    Le Bars, Herve
    Hery-Arnaud, Genevieve
    MICROORGANISMS, 2021, 9 (12)
  • [28] Comparative in vitro activities of eravacycline in combination with colistin, meropenem, or ceftazidime against various Achromobacter spp. strains isolated from patients with cystic fibrosis
    Ozer, Bekir
    Celik, Berna Ozbek
    JOURNAL OF CHEMOTHERAPY, 2023, 35 (08) : 700 - 706
  • [29] Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates
    Tramper-Stranders, G. A.
    van der Ent, C. K.
    Molin, S.
    Yang, L.
    Hansen, S. K.
    Rau, M. H.
    Ciofu, O.
    Johansen, H. K.
    Wolfs, T. F. W.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (06) : 567 - 574
  • [30] Use of nrdA gene sequence clustering to estimate the prevalence of different Achromobacter species among Cystic Fibrosis patients in the UK
    Coward, Amy
    Kenna, Dervla T. D.
    Perry, Claire
    Martin, Kate
    Doumith, Michel
    Turton, Jane F.
    JOURNAL OF CYSTIC FIBROSIS, 2016, 15 (04) : 479 - 485